Simbec-Orion (NL)
Simbec-Orion (NL) is recorded as a service provider in 2 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 2 of 2 trials · Latest update first
Open-label clinical phase 1/2 study to assess the safety and efficacy of the SpectraCure P18 System (Interstitial multiple diode lasers and IDOSE® Software) and verteporfin for injection (VFI) for the treatment of recurrent prostate cancer
Sponsor SpectraCure AB (publ)
- Start (EU)
- Latest update
- Estimated end
Open-label clinical phase 1/2 study to assess the safety and efficacy of the SpectraCure P18 System and verteporfin for injection for the treatment of primary localized prostate cancer
Sponsor SpectraCure AB (publ)
- Start (EU)
- Not reported
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Simbec-Orion (NL)?
The 2026-10-09 snapshot links Simbec-Orion (NL) to 2 distinct CTIS trials. Recorded services include Data management, Statistics, parts of study management. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Simbec-Orion (NL)?
Therapeutic-area tags are not recorded in this snapshot. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Simbec-Orion (NL) conducted?
The linked trials record locations in 2 countries, including Germany, Sweden. These are trial locations, not confirmed office locations or countries where Simbec-Orion (NL) delivered services.
What can this page tell me about Simbec-Orion (NL)'s trial experience?
Browse 2 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Simbec-Orion (NL). Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Simbec-Orion (NL) B.V.